Bruker Corp. (BRKR) intrinsic value & 10-year financials

Bruker Corp. (BRKR) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 8.8% a year to $3.4B, with an average return on invested capital of 16.2%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$54.80
Market cap
$8.3B
Revenue (FY2025)
$3.4B
Revenue growth (10-yr CAGR)
8.8%
ROIC (10-yr avg)
16.2%
Free cash flow (FY2025)
$43.3M

BRKR 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $3.4B -$8.6M -$0.15 $43.3M 2.0% 0.9%
FY2024 $3.4B $113.1M $0.00 $136.0M 7.5% 4.7%
FY2023 $3.0B $427.2M $0.00 $243.2M 14.7% 17.8%
FY2022 $2.5B $296.6M $0.00 $145.2M 17.1% 20.8%
FY2021 $2.4B $277.1M $0.00 $190.4M 17.1% 24.1%
FY2020 $2.0B $157.8M $0.00 $235.0M 12.5% 15.9%
FY2019 $2.1B $197.2M $0.00 $140.4M 14.5% 21.7%
FY2018 $1.9B $179.7M $0.00 $190.5M 13.8% 22.4%
FY2017 $1.8B $78.6M $0.00 $110.7M 12.2% 13.7%
FY2016 $1.6B $153.6M $0.00 $93.7M 11.0% 20.4%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

BRUKER CORP is a consistent compounder, expanding top-line revenue at 8.8% annually over the past decade.

BRUKER CORP has earned high returns on invested capital, averaging 16.2% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Over the decade, BRUKER CORP shows that management has aggressively returned capital to shareholders by retiring 100.0% of outstanding shares, and that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, BRUKER CORP is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.00 per share.

BRKR stock: frequently asked questions

What is the intrinsic value of Bruker Corp. (BRKR) stock?

Graham's formula only works with positive earnings. Bruker Corp. reported diluted EPS of -$0.15 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

How fast has Bruker Corp. grown?

Revenue went from $1.6B in fiscal 2016 to $3.4B in fiscal 2025, a compound annual growth rate of 8.8%. Net income was -$8.6M in fiscal 2025.

Does Bruker Corp. generate free cash flow?

Bruker Corp. generated $43.3M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 10 of the last 10 reported years.

What is BRKR's return on invested capital?

Average ROIC over the last 10 fiscal years was 16.2%, and average return on equity was 19.0%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this BRKR data come from?

From Bruker Corp.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 5, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar laboratory analytical instruments stocks